Digbi Health today announced incorporating ethnic-specific risk scores for nutrition, fitness, obesity, diabetes, hypertension, mental and digestive health across its virtual care program for people living with polychronic physical and mental illness associated with inflammatory gut and weight.
It's well established that risk of illness, food allergies, gut microbiome composition, and pharmaceutical risk varies significantly by ethnicity and gender because they are rooted in the genetics and gut microbiome of an individual - A) African Americans have a higher genetic risk for hypertension and lung cancer despite lower smoking rates, B) black women are more likely to get breast cancer, C) Hispanic adults have higher risks of diabetes. D) Asian Indian men have four times higher risk of cardiovascular disease even if with a normal BMI, non-smoking and vegetarian E) white European males have a higher risk of Atrial Fibrillation, F) Jews of European descent have one of the highest risks of developing colon cancer compared to any ethnicity worldwide and, G) white women have a higher risk of a digestive and inflammatory disease like arthritis.¹
Genetic testing has become increasingly widespread, with millions of Americans conducting genetic tests at home. Employers and health plans are embracing digital care programs for their employees. Despite the popularity, current genetic tests and digital care programs fail to account for gender and ethnic diversity.
Specifically, 78% of genetic studies come from people of predominantly European descent and most digital care guidelines are predominantly based on studies done with the white male population, even though they only make up 16% of the population², resulting in significant inequity in care outcomes for women and people of color.
Digbi's new genetic scores address these health outcome inequities and care is personalized using the member's ethnic ancestry, measured by their DNA sequence, gut microbiome, food habits, and food preference. In a recently published study of 393 adults, Digbi's polychronic care program proved to be equally effective across ethnicities and income levels.
"It's extremely problematic for the health of an increasingly diverse workforce to limit genetic, gut microbiome data to one population and one-size-fits-all digital care programs that have proven bias towards one gender and ethnicity. Digbi's science and care team is committed to eliminating health outcome disparities while advancing our understanding of genetic and gut microbiome science," said Ranjan Sinha, Founder and Chief Executive Officer of Digbi Health.